AbbVie

Lupron-Depot PED®

leuprolide acetate for depot suspension, A GnRH agonist indicated for the treatment of central precocious puberty (CPP) in pediatric patients.

Treatment for Central Precocious Puberty

Lupron-Depot PED® is a monthly depot injection containing leuprolide acetate that acts as a GnRH agonist. It inhibits the action of gonadotropin-releasing hormone, suppressing the premature activation of the hypothalamic-pituitary-gonadal axis responsible for central precocious puberty.

  • GnRH agonist, inhibits gonadotropin-releasing hormone
  • Monthly (1-month) and 3-month depot formulations
  • Proven to suppress pubertal progression in CPP
  • Long-established safety profile in pediatric patients
Central Precocious Puberty

Occurs when puberty begins too early in children, Lupron-Depot PED® helps halt premature development safely.

Patient & Clinical Resources

Back to Growth Disorders
Traveling with your medication? This medication requires refrigeration. Our partner 4AllFamily offers insulin coolers and medical travel cases to keep your medication safe wherever you go.
Shop Now

Questions About Lupron-Depot PED®?

Our clinical pharmacists can answer questions about administration, insurance coverage, and patient support resources.